BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 25385004)

  • 1. Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
    Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H
    Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor targeting strategies for chitosan-based nanoparticles.
    Zhang X; Yang X; Ji J; Liu A; Zhai G
    Colloids Surf B Biointerfaces; 2016 Dec; 148():460-473. PubMed ID: 27665379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
    Kamath PR; Sunil D
    Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.
    Ang CY; Tan SY; Zhao Y
    Org Biomol Chem; 2014 Jul; 12(27):4776-806. PubMed ID: 24737243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles.
    Alhodieb FS; Barkat MA; Barkat HA; Hadi HA; Khan MI; Ashfaq F; Rahman MA; Hassan MZ; Alanezi AA
    Int J Biol Macromol; 2022 Sep; 217():457-469. PubMed ID: 35798082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
    Tanbour R; Martins AM; Pitt WG; Husseini GA
    Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of protein- and Peptide-based nanoparticles as potential vehicles for anticancer drugs.
    Elzoghby AO; Elgohary MM; Kamel NM
    Adv Protein Chem Struct Biol; 2015; 98():169-221. PubMed ID: 25819280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
    Torchilin VP
    AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
    Olov N; Bagheri-Khoulenjani S; Mirzadeh H
    J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect.
    Senthilkumar R; Karaman DŞ; Paul P; Björk EM; Odén M; Eriksson JE; Rosenholm JM
    Biomater Sci; 2015 Jan; 3(1):103-11. PubMed ID: 26214194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
    Zhang J; Tang H; Liu Z; Chen B
    Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-based nanoparticles for tumor-targeted drug delivery.
    Prabaharan M
    Int J Biol Macromol; 2015 Jan; 72():1313-22. PubMed ID: 25450550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-coated gold nanorods for cancer therapy combining chemical and photothermal effects.
    Duan R; Zhou Z; Su G; Liu L; Guan M; Du B; Zhang Q
    Macromol Biosci; 2014 Aug; 14(8):1160-9. PubMed ID: 24789052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in chitosan-based nanoparticles for oncotherapy.
    Zhang E; Xing R; Liu S; Qin Y; Li K; Li P
    Carbohydr Polym; 2019 Oct; 222():115004. PubMed ID: 31320066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.